RIO DE JANEIRO, Brazil, July 28 /PRNewswire-FirstCall/ -- One of Brazil’s leading distributors of pharmaceutical products, Profarma Distribuidora de Produtos Farmaceuticos S.A. (“Profarma” or the “Company”) (Bovespa: PFRM3) has just announced its results for the second quarter of 2008 (2Q08).
HIGHLIGHTS FOR THE PERIOD
-- A growth of 21.8% of the consolidated Gross Revenue when compared to the same period of the previous year, having reached R$ 742.8 million.
-- The adjusted EBITDA was R$ 23.9 million, a growth of 21.6% in relation to the one registered in the 2Q07 of R$ 19.7 million.
-- Profarma’s market share reached 11.8% in the 2Q08, 1.1 percentage points above the one reached during the same period of the previous year.
-- Profarma contracted the services of UBS Pactual S.A. bank, on May 29, 2008, to be the market maker of its shares in order to promote their liquidity.
-- Profarma opened on July 14, 2008 its first exclusive distribution center for the hospital and vaccine segment in the state of Sao Paulo.
CONTACT: Max Fischer, CFO & IRO, or Beatriz Diez, IR Coordinator, both of
Profarma, +011-55-21-4009-0276, Fax, +011-55-21-2491-3906,
ri@profarma.com.br
Web site: http://www.profarma.com.br/ir/
